​

Funding Round

Series C - Realeve

Series C - Realeve

Investment Firm

Overview

Realeve develops miniaturized neurostimulation devices designed to set a new standard in treating severe headache.

Announced Date

Oct 11, 2011

Funding Type

Series C

Highlights

Location

United States, North America

Social

Investor Lead

Novartis Venture Fund

Novartis Venture Fund

Novartis Venture Fund is a early_stage_venture and late_stage_venture and post_ipo and seed firm.

Aberdare Ventures

Aberdare Ventures

Aberdare Ventures is a early_stage_venture and grant and late_stage_venture and private_equity and seed firm.

Participant Investors

4

Investor Name
Participant InvestorAberdare Ventures
Participant InvestorNovartis Venture Fund
Participant InvestorVersant Ventures
Participant InvestorKleiner Perkins

Round Details and Background

Realeve raised $32000000 on 2011-10-11 in Series C

Realeve develops miniaturized neurostimulation devices designed to set a new standard in treating severe headache.

Company Funding History

6

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
May 12, 2015
Series D - Realeve
7-38.0M
Oct 11, 2011
Series C - Realeve
4-32.0M
Jan 14, 2008
Series A - Realeve
1-3.0M
May 22, 2009
Series B - Realeve
3-20.0M

Recent Activity

There is no recent news or activity for this profile.